What is Amnesia & How is it Treated?

Health & Lifestyle
260

Listen to article (english)

Translate to Spanish or other 102 languages!

Amnesia is when a person can no longer recall information stored in their memory. There are many types of amnesia. Their symptoms can overlap, and a person can have multiple types. Image for illustration purposes
Amnesia is when a person can no longer recall information stored in their memory. There are many types of amnesia. Their symptoms can overlap, and a person can have multiple types. Image for illustration purposes

Medical News Today

- Advertisement -

Amnesia is when a person can no longer recall information stored in their memory. There are many types of amnesia. Their symptoms can overlap, and a person can have multiple types.

A person who is a little forgetful in their day-to-day life does not have amnesia. Amnesia refers to a large-scale loss of long-term memory due to illness, brain injury, or psychological traum

Follow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/9673?slot_pos=article_3&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-02-18&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Why It’s Okay for Kids to be Bored
Next article
FDA Proposes Reducing Nicotine Levels in Certain Tobacco Products

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -